The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review
The Pharmacogenomics Journal, Published online: 17 June 2021; doi:10.1038/s41397-021-00224-wThe impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 17, 2021 Category: Drugs & Pharmacology Authors: Erika L. Meaddough Sara M. Sarasua Tracy K. Fasolino Christopher L. Farrell Source Type: research
Conference report: inaugural Pharmacogenomics Access & Reimbursement Symposium
The Pharmacogenomics Journal, Published online: 17 June 2021; doi:10.1038/s41397-021-00240-wThe Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition (PARC), was a one-day interactive meeting comprised of plenary keynotes from thought leaders across health care that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened t...
Source: The Pharmacogenomics Journal - June 17, 2021 Category: Drugs & Pharmacology Authors: Sara L. Rogers George P. Patrinos Christina Mitropoulou Christine M. Formea J. Shawn Jones Benjamin G. Brown Source Type: research
Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations
The Pharmacogenomics Journal, Published online: 15 June 2021; doi:10.1038/s41397-021-00243-7Genetic-guided pharmacotherapy for venous thromboembolism: a systematic and critical review of economic evaluations (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 15, 2021 Category: Drugs & Pharmacology Authors: Ka Keat Lim Rositsa Koleva-Kolarova Philip Chowienczyk Charles D. A. Wolfe Julia Fox-Rushby Source Type: research
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease
The Pharmacogenomics Journal, Published online: 01 June 2021; doi:10.1038/s41397-021-00244-6Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - June 1, 2021 Category: Drugs & Pharmacology Authors: Amanda L. Elchynski Emily J. Cicali Maria C. Ferrer del Busto Alessandra Hamilton Ku-Lang Chang Siegfried O. Schmidt Brian Weiner Richard Davis David Estores D. Max Smith Kristin Wiisanen Julie A. Johnson Larisa H. Cavallari Source Type: research
Gene expression signatures predict response to therapy with growth hormone
The Pharmacogenomics Journal, Published online: 27 May 2021; doi:10.1038/s41397-021-00237-5Gene expression signatures predict response to therapy with growth hormone (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 27, 2021 Category: Drugs & Pharmacology Authors: Adam Stevens Philip Murray Chiara De Leonibus Terence Garner Ekaterina Koledova Geoffrey Ambler Klaus Kapelari Gerhard Binder Mohamad Maghnie Stefano Zucchini Elena Bashnina Julia Skorodok Diego Yeste Alicia Belgorosky Juan-Pedro Lopez Siguero Regis Couta Source Type: research
Overexpression of P-glycoprotein and MRP-1 are pharmacogenomic biomarkers to determine steroid resistant phenotype in childhood idiopathic nephrotic syndrome
The Pharmacogenomics Journal, Published online: 19 May 2021; doi:10.1038/s41397-021-00233-9Overexpression of P-glycoprotein and MRP-1 are pharmacogenomic biomarkers to determine steroid resistant phenotype in childhood idiopathic nephrotic syndrome (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - May 19, 2021 Category: Drugs & Pharmacology Authors: Narayan Prasad Harshit Singh Akhilesh Jaiswal Saurabh Chaturvedi Vikas Agarwal Source Type: research
A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review
The Pharmacogenomics Journal, Published online: 13 April 2021; doi:10.1038/s41397-021-00236-6A Decade of Pharmacogenetic Studies in Jordan: A Systemic Review (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 13, 2021 Category: Drugs & Pharmacology Authors: Alaa Yehya Zaid Altaany Source Type: research
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment
The Pharmacogenomics Journal, Published online: 13 April 2021; doi:10.1038/s41397-021-00235-7ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 13, 2021 Category: Drugs & Pharmacology Authors: Stefania Cheli Sara Baldelli Annalisa De Silvestri Marta Fusi Davide Minisci Cristina Gervasoni Dario Cattaneo Emilio Clementi Paola Meraviglia Cristina Montrasio Source Type: research
Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study
The Pharmacogenomics Journal, Published online: 06 April 2021; doi:10.1038/s41397-021-00234-8Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 6, 2021 Category: Drugs & Pharmacology Authors: Katrine K. Fjukstad Lavinia Athanasiu Shahram Bahrami Kevin S. O ’Connell Dennis van der Meer Francesco Bettella Ingrid Dieset Nils Eiel Steen Srdjan Djurovic Olav Spigset Ole A. Andreassen Source Type: research
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
The Pharmacogenomics Journal, Published online: 06 April 2021; doi:10.1038/s41397-021-00225-9Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - April 6, 2021 Category: Drugs & Pharmacology Authors: Rika Yuliwulandari Jae Gook Shin Erna Kristin Fransiscus D. Suyatna Iwan Dwi Prahasto Kinasih Prayuni Surakameth Mahasirimongkol Larisa H. Cavallari Christina Mitropoulou George P. Patrinos Jing Hao Marc S. Williams Susan R. Snyder Source Type: research
A survey of cancer genome signatures identifies genes connected to distinct chromosomal instability phenotypes
The Pharmacogenomics Journal, Published online: 17 March 2021; doi:10.1038/s41397-021-00217-9A survey of cancer genome signatures identifies genes connected to distinct chromosomal instability phenotypes (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - March 17, 2021 Category: Drugs & Pharmacology Authors: Manar S. Shafat Eamaan S. Rufaie Johnathan Watkins Source Type: research
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes
The Pharmacogenomics Journal, Published online: 17 March 2021; doi:10.1038/s41397-021-00229-5Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - March 17, 2021 Category: Drugs & Pharmacology Authors: E. O ’Connell I. S. Reynolds M. Salvucci D. A. McNamara J. P. Burke J. H. M. Prehn Source Type: research
Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder
The Pharmacogenomics Journal, Published online: 17 March 2021; doi:10.1038/s41397-021-00228-6Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - March 17, 2021 Category: Drugs & Pharmacology Authors: Ibrahim Mohammed Badamasi Munn Sann Lye Normala Ibrahim Nurul Asyikin Abdul Razaq King Hwa Ling Johnson Stanslas Source Type: research
Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients
The Pharmacogenomics Journal, Published online: 17 March 2021; doi:10.1038/s41397-021-00231-xClinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - March 17, 2021 Category: Drugs & Pharmacology Authors: Helmi Ammar Zohra Chadli Ahmed Mhalla Sabria Khouadja Ibtissem Hannachi Mohammed Alshaikheid Ahlem Slama Nadia Ben Fredj Najeh Ben Fadhel Haifa Ben Romdhane Amel Chaabane Naceur A. Boughattas Lotfi Gaha Lazhar Zarrouk Karim Aouam Source Type: research
Pharmacogenetic-guided glimepiride therapy in type-2 diabetes mellitus: a cost-effectiveness study
The Pharmacogenomics Journal, Published online: 17 March 2021; doi:10.1038/s41397-021-00232-wPharmacogenetic-guided glimepiride therapy in type-2 diabetes mellitus: a cost-effectiveness study (Source: The Pharmacogenomics Journal)
Source: The Pharmacogenomics Journal - March 17, 2021 Category: Drugs & Pharmacology Authors: C écile Fokoun Hassan Serrier Hugo Rabier Sylvain Goutelle Michel Tod Laurent Bourguignon Source Type: research
